Literature DB >> 16699269

Opioid-induced gastrointestinal dysfunction.

Sangeeta R Mehendale1, Chun-Su Yuan.   

Abstract

Use of opioid analgesics is associated with a number of side effects, especially opioid-induced gastrointestinal dysfunction. The extensive use of these compounds and the significant negative impact of the resulting gastrointestinal dysfunction on patients' quality of life make it an important clinical issue. In recent years our understanding of the mechanisms of opioid-induced gastrointestinal dysfunction has advanced greatly. This article reviews the underlying pathophysiological mechanisms of specific gastrointestinal adverse effects of opioids. The role of endogenous opioid peptides in certain gastrointestinal diseases is also discussed. A better understanding of the pathophysiological mechanisms of opioid-induced bowel dysfunction should lead to the development of newer opioid analgesics and improved regimens resulting in reduced gastrointestinal adverse effects. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699269     DOI: 10.1159/000090314

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  17 in total

1.  Effects of nociceptin/orphanin FQ on rats with cathartic colon.

Authors:  Hai-Yan Li; Xiang Yan; Quan-Lai Xue; Yong-Ning Zhou; Yan Gao; Rui Wang; Yong-Ming Liu; Jun-Tao Ran
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Opioid-induced bowel dysfunction.

Authors:  Gyanprakash A Ketwaroo; Vivian Cheng; Anthony Lembo
Journal:  Curr Gastroenterol Rep       Date:  2013-09

3.  Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.

Authors:  Shiva K Ratuapli; Michael D Crowell; John K DiBaise; Marcelo F Vela; Francisco C Ramirez; George E Burdick; Brian E Lacy; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 4.  Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics.

Authors:  Jeanne M Manubay; Carrie Muchow; Maria A Sullivan
Journal:  Prim Care       Date:  2011-03       Impact factor: 2.907

Review 5.  The relationship between opioid and sugar intake: review of evidence and clinical applications.

Authors:  David J Mysels; Maria A Sullivan
Journal:  J Opioid Manag       Date:  2010 Nov-Dec

6.  Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.

Authors:  R E Williams; N Bosnic; C T Sweeney; A W Duncan; K B Levine; M Brogan; S F Cook
Journal:  Pain Res Manag       Date:  2008 Sep-Oct       Impact factor: 3.037

7.  Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.

Authors:  Cornelius E J Sloots; An Rykx; Marina Cools; Rene Kerstens; Martine De Pauw
Journal:  Dig Dis Sci       Date:  2010-04-30       Impact factor: 3.199

8.  The narcotic bowel syndrome: clinical features, pathophysiology, and management.

Authors:  David M S Grunkemeier; Joseph E Cassara; Christine B Dalton; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10       Impact factor: 11.382

9.  Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-04-14       Impact factor: 10.864

10.  Associations between medication use and functional gastrointestinal disorders: a population-based study.

Authors:  R S Choung; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2013-01-29       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.